Cullinan Therapeutics Statistics

Total Valuation

CGEM has a market cap or net worth of $451.33 million. The enterprise value is $187.37 million.

Market Cap	451.33M
Enterprise Value	187.37M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CGEM has 59.07 million shares outstanding. The number of shares has increased by 27.94% in one year.

Current Share Class	59.07M
Shares Outstanding	59.07M
Shares Change (YoY)	+27.94%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	3.98%
Owned by Institutions (%)	76.26%
Float	36.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.92
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.83, with a Debt / Equity ratio of 0.00.

Current Ratio	9.83
Quick Ratio	9.46
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.01% and return on invested capital (ROIC) is -25.45%.

Return on Equity (ROE)	-36.01%
Return on Assets (ROA)	-24.42%
Return on Invested Capital (ROIC)	-25.45%
Return on Capital Employed (ROCE)	-47.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.86M
Employee Count	111
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CGEM has paid $117,000 in taxes.

Income Tax	117,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.13% in the last 52 weeks. The beta is -0.07, so CGEM's price volatility has been lower than the market average.

Beta (5Y)	-0.07
52-Week Price Change	-53.13%
50-Day Moving Average	8.00
200-Day Moving Average	9.79
Relative Strength Index (RSI)	48.30
Average Volume (20 Days)	339,447

Short Selling Information

The latest short interest is 6.45 million, so 10.91% of the outstanding shares have been sold short.

Short Interest	6.45M
Short Previous Month	5.88M
Short % of Shares Out	10.91%
Short % of Float	17.88%
Short Ratio (days to cover)	20.96

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-234.70M
Pretax Income	-156.28M
Net Income	-206.76M
EBITDA	-234.39M
EBIT	-234.70M
Earnings Per Share (EPS)	-$3.52

Full Income Statement

Balance Sheet

The company has $265.48 million in cash and $1.52 million in debt, giving a net cash position of $263.96 million or $4.47 per share.

Cash & Cash Equivalents	265.48M
Total Debt	1.52M
Net Cash	263.96M
Net Cash Per Share	$4.47
Equity (Book Value)	492.15M
Book Value Per Share	8.33
Working Capital	247.85M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-171.53M
Capital Expenditures	n/a
Free Cash Flow	-171.53M
FCF Per Share	-$2.90

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.94%
Shareholder Yield	n/a
Earnings Yield	-45.81%
FCF Yield	-38.01%

Analyst Forecast

The average price target for CGEM is $28.17, which is 268.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.17
Price Target Difference	268.72%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	2.48%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1